Capricor
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Capricor and other ETFs, options, and stocks.About CAPR
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine.
CAPR Key Statistics
Stock Snapshot
The current Capricor(CAPR) stock price is $7.84, with a market capitalization of 452.32M. The stock trades at a price-to-earnings (P/E) ratio of -3.18.
On 2026-10-06, Capricor(CAPR) stock moved within a range of $7.82 to $7.84. With shares now at $7.84, the stock is trading +0.2% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 17K, compared to an average daily volume of 4.86M.
The stock's 52-week range extends from a low of $2.96 to a high of $40.37.
The stock's 52-week range extends from a low of $2.96 to a high of $40.37.
CAPR News
...
Capricor Therapeutics (CAPR) this morning announced new data from its ongoing HOPE-3 open-label extension study for its lead asset, Deramiocel, for the treatmen...
Shares of Capricor Therapeutics Inc. (NASDAQ:CAPR) are trading higher Wednesday morning following the release of positive long-term clinical data for its lead c...
Analyst ratings
60%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.